Neurology Medical News about Churg–Strauss syndrome; neuropathy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clinical characterization and successful treatment of 6 patients with Churg–Strauss syndrome-associated neuropathy
Clinical Neurology and Neurosurgery, 09/01/09

Nakamura M et al. – The study showed that CSS–associated neuropathy is a treatable disorder and that the first choice therapy is high–dose corticosteroid. In cases where corticosteroids are ineffective or for severe cases, immunosuppressive therapy (cyclophosphamide) with steroids should be considered, and IVIg might be a treatment option.

<< Previous
Communication outcome after stroke: a new measure of the carer’s...

Next >>
Multiple cognitive deficits in patients during the mild cognitive...